Ferroptosis in organ fibrosis: From mechanisms to therapeutic medicines

Weijing Lai,Bo Wang,Rongshuang Huang,Chuyue Zhang,Ping Fu,Liang Ma
DOI: https://doi.org/10.2478/jtim-2023-0137
2024-02-01
Journal of Translational Internal Medicine
Abstract:Abstract Fibrosis occurs in many organs, and its sustained progress can lead to organ destruction and malfunction. Although numerous studies on organ fibrosis have been carried out, its underlying mechanism is largely unknown, and no ideal treatment is currently available. Ferroptosis is an iron-dependent process of programmed cell death that is characterized by lipid peroxidation. In the past decade, a growing body of evidence demonstrated the association between ferroptosis and fibrotic diseases, while targeting ferroptosis may serve as a potential therapeutic strategy. This review highlights recent advances in the crosstalk between ferroptosis and organ fibrosis, and discusses ferroptosis-targeted therapeutic approaches against fibrosis that are currently being explored.
medicine, general & internal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the relationship between ferroptosis and organ fibrosis, and to evaluate the potential of ferroptosis - targeted treatment strategies in combating fibrotic diseases. Specifically, the article summarizes the research progress in recent years on the interaction between ferroptosis and organ fibrosis, discusses the mechanisms of the ferroptosis - driving system and the defense system, and how ferroptosis participates in the fibrotic processes of different organs (such as the kidney, lung, heart and liver) by promoting processes such as inflammation and epithelial - mesenchymal transition (EMT). In addition, the article also introduces some ferroptosis - targeted strategies that may be used to treat fibrosis currently discovered in research, including the mechanisms of action and their effects of natural active ingredients and marketed drugs. The main objective of the article is to provide a comprehensive perspective to understand the mechanism of ferroptosis in fibrotic diseases, thereby providing a theoretical basis and potential therapeutic targets for the development of new anti - fibrotic treatment methods. This not only helps to deepen the understanding of the pathophysiological mechanisms of fibrosis, but also provides new ideas for clinical treatment.